All In MedTech

Device Trial Radar · NCT06450444

The RECLAIM Study.

Randomized, Double-blind, Controlled Trial to Investigate Combined Occipital and Supra-orbital Neuromodulation in Resistant Migraine. The RECLAIM Study.

Last checked: Nov 20, 2026Latest source record: Aug 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 110 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

110

Planned (sponsor's estimate)

Start

Jun 24, 2024

Primary completion

Apr 1, 2027

Study completion Jan 31, 2029

Sponsor

Lead sponsor
Salvia BioElectronicsNot on our public-company list
Sponsor type
Industry
First posted
Jun 10, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 84 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.

Conditions

  • Chronic Migraine
  • High Frequency Episodic Migraine

Interventions

  • PRIMUSDevice

    The Salvia PRIMUS System is designed to provide subcutaneous neurostimulation to the branches of the trigeminal and occipital nerves.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety EvaluationTime frame: 12 weeks
  2. Effectiveness EvaluationTime frame: 12 weeks

Locations

11 sites in 3 countries. Site status is shown where the registry gives one.

  • Genesis Research Services

    Broadmeadow, New South Wales, Australia · Terminated

  • Resolve Pain

    Buderim, Queensland, Australia · Terminated

  • ZAS Antwerpen, Campus Sint-Augustinus

    Wilrijk, Antwerpen, Belgium · Recruiting

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.